PAG, a global investment firm, completed a $200m investment in RK Pharma, a vertically integrated pharmaceutical company. “We are pleased to be partnering with PAG, an established investment firm with a successful track record of supporting leading companies in the pharmaceutical space. This transformative investment by PAG would help ensure that RK Pharma can accelerate its growth plans, partnerships, and develop/ launch further innovative medicines for the benefit of patients; and strengthen RK Pharma’s position as a leading fully vertically integrated specialty injectable and ophthalmic pharmaceutical company,” Ravishanker Kovi, RK Pharm Founder and Executive Chairman.